Attached files
| file | filename |
|---|---|
| 8-K - BOVIE 8K RE CRANSHIRE - Apyx Medical Corp | bovie8krecranshire.htm |
| EX-10.3 - FORM OF WARRANT RE SECURITIES PURCHASE AGREEMENT - Apyx Medical Corp | boviemedicalwarrant.htm |
| EX-10.4 - FORM OF WARRANT RE PLACEMENT AGREEMENT - Apyx Medical Corp | bovieplacementwarrant.htm |
| EX-10.1 - EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT - Apyx Medical Corp | securitiespurchaseagmt.htm |
| EX-10.2 - EXHIBIT 10.2 FORM OF REGISTRATION RIGHTS AGREEMENT - Apyx Medical Corp | registrationrightsagreement.htm |
BOVIE
MEDICAL CORPORATION ANNOUNCES $3 MILLION PRIVATE PLACEMENT
Melville,
New York, April 19, 2010 - Bovie Medical Corporation (the “Company”) (AMEX:BVX)
today announced it entered into a definitive agreement on April 18, 2010, to
sell securities to institutional investors in a private placement for aggregate
gross proceeds of approximately $3 million. The closing of the offering is
subject to the satisfaction of customary closing conditions.
Under the
terms of the offering, Bovie will sell 571,429 shares of common stock in the
aggregate at a price of $5.25 per share. The purchasers will also
receive warrants to purchase 285,714 shares of common stock in the aggregate
which are exercisable immediately and have an exercise price of $6.00 per share
and a term of 5 years. The exercise price of the warrants may be
adjusted in the event of subsequent events, including stock splits and dividends
and the issuance of securities at a price that is less than the exercise price
of warrants then in effect. Net proceeds from the offering will be
used for general working capital purposes. Bovie is required to file a resale
registration statement within 30 days following the closing that covers the
resale by the purchasers of the shares and the shares issuable upon exercise of
the warrants.
Andrew
Makrides, President of Bovie Medical, stated, “We believe the participation of
institutional investors is evidence of the confidence the investment community
has placed in our company, while strengthening our ability to develop and market
our proprietary technologies for the medical industry.”
Rodman
& Renshaw, LLC, a wholly owned subsidiary of Rodman & Renshaw Capital
Group, Inc. (NASDAQ:RODM - News), acted as the
exclusive placement agent for the offering.
This
press release shall not constitute an offer to sell or the solicitation of an
offer to buy securities. The securities offered and sold in the private
placement have not been registered under the Securities Act of 1933, as amended,
or any state securities laws, and may not be offered or sold in the United
States absent registration,
or an applicable exemption from registration under the Securities Act and
applicable state securities laws.
Bovie
Medical Corporation, headquartered in Melville, New York, develops, manufactures
and markets medical products and devices with a strong emphasis in
electrosurgical generators and electrosurgical disposables.
Certain
matters discussed in this news release and oral statements made from time to
time by representatives of the Company may constitute forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995 and
the Federal securities laws. Although the Company believes that the
expectations reflected in such forward-looking statements are based upon
reasonable assumptions, it can give no assurance that its expectations will be
achieved.
Forward-looking
information is subject to certain risks, trends and uncertainties that could
cause actual results to differ materially from those projected. Many
of these factors are beyond the Company’s ability to control or
predict. Important factors that may cause actual results to differ
materially and that could impact the Company and the statements contained in
this news release can be found in the Company’s filings with the Securities and
Exchange Commission. For forward-looking statements in this new
release, the Company claims the protection of the safe harbor for
forward-looking statements contained in the Private Securities Litigation Reform
Act of 1995. The Company assumes no obligation to update or
supplement any forward-looking statements whether as a result of new
information, future events or otherwise.
Investor
Contact:
|
Rodman
& RenshawBovie Medical Corp.
|
Bovie
Medical Corp.
|
|
Buttonwood
Advisory Group, Inc.
|
|
|
John
Aneralla
|
|
|
800-940-9087
|